 SEATTLE, Jan. 04, 2022 GLOBE NEWSWIRE -- Sana Biotechnology, Inc. NASDAQ: SANA, a company focused on creating and delivering engineered cells as medicines, today announced that it will webcast its presentation at the 40th Annual J.P. Morgan Healthcare Conference at 10:30 a.m. PT on Tuesday, January 11, 2022. The presentation will feature a business overview and update by Steve Harr, Sanas President and Chief Executive Officer. 